Home / Companies / PDS Biotechnology Corporation / 24 Jun 2024
PDS Biotechnology Corporation: meeting of 24 Jun 2024
Votes reported on Form N-PX, item by item
126 Form N-PX filers reported votes at the PDS Biotechnology Corporation meeting of 24 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 54.3% of reported votes for; 29 filers withheld from or voted against at least one nominee.
166 vote records from 49 filers. 18 of the 48 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
174 vote records from 124 filers. 30 of the 118 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
83 vote records from 49 filers. 0 of the 48 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
83 vote records from 49 filers. 4 of the 48 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | Abstain or withhold * | Against * | For |
| State Street and SPDR | Split or no vote | For | For |
| Invesco | For | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | Split or no vote | For | For |
| ProShares and ProFunds | Abstain or withhold * | For | For |
| John Hancock and Manulife | Abstain or withhold * | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | No report | For | No report |
| PGIM and Prudential | No report | Against * | No report |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | No report | Against * | No report |
| T. Rowe Price | For | For | For |
| Lincoln Financial | Split or no vote | For | For |
| Voya | Split or no vote | For | For |
| Nationwide | For | Against * | For |
| Victory Capital | Abstain or withhold * | For | For |
| Brighthouse Funds | Abstain or withhold * | For | For |
| Guggenheim and Rydex | Abstain or withhold * | For | For |
| Columbia Threadneedle | No report | For | No report |
| BNY Mellon | No report | For | No report |
| Principal | Abstain or withhold * | For | For |
| Pacific Life funds | For | For | For |
| Global X | For | Against * | For |
| AllianceBernstein | No report | For | No report |
| DWS | Abstain or withhold * | For | For |
| Neuberger Berman | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the PDS Biotechnology Corporation meeting?
126 Form N-PX filers reported votes at the meeting of 24 Jun 2024. On say-on-pay, 30 of 118 voted against management (25.4%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by PDS Biotechnology Corporation on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for PDS Biotechnology Corporation
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing PDS Biotechnology Corporation with a meeting date within three days of 24 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.